And I think Southoz is clearly the resident expert in clinical trial stats, so if you don't mind I prefer his opinion over your good self and the other posters. He also set out his reasoning and I don't see any reason not to accept it.
CEO Itescu needs to go, page-147
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.10 |
Change
0.005(0.46%) |
Mkt cap ! $1.230B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.10 | $1.07 | $2.365M | 2.194M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 34 | 73362 | $1.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.10 | 92775 | 12 |
View Market Depth
| Last trade - 12.05pm 11/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |